14.31
7.67%
1.02
アフターアワーズ:
14.50
0.19
+1.33%
前日終値:
$13.29
開ける:
$13.17
24時間の取引高:
4.49M
Relative Volume:
2.42
時価総額:
$1.73B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-7.4921
EPS:
-1.91
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+7.27%
1か月 パフォーマンス:
-5.48%
6か月 パフォーマンス:
-40.55%
1年 パフォーマンス:
-66.99%
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
TXG | 14.31 | 1.73B | 631.73M | -239.78M | -33.45M | -1.91 |
VEEV | 216.58 | 35.07B | 2.57B | 615.26M | 996.76M | 3.32 |
SOLV | 70.81 | 12.23B | 8.26B | 66.00M | 1.17B | 0.00 |
DOCS | 48.20 | 9.00B | 493.63M | 160.55M | 162.20M | 0.55 |
TEM | 58.60 | 9.23B | 640.44M | -743.28M | -206.93M | 0.00 |
HQY | 104.25 | 8.98B | 1.10B | 105.67M | -197.98M | 0.1475 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-09-03 | 開始されました | Leerink Partners | Outperform |
2024-07-22 | アップグレード | Jefferies | Hold → Buy |
2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
2024-06-03 | 再開されました | Jefferies | Hold |
2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
2023-12-14 | 開始されました | Guggenheim | Buy |
2023-12-13 | 開始されました | Wolfe Research | Outperform |
2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
2023-07-05 | 再開されました | JP Morgan | Overweight |
2023-05-10 | 開始されました | Barclays | Overweight |
2023-03-31 | 開始されました | Stephens | Overweight |
2023-02-02 | 開始されました | UBS | Neutral |
2022-12-14 | 開始されました | Deutsche Bank | Buy |
2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
2022-07-25 | 開始されました | Canaccord Genuity | Buy |
2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
2021-10-15 | 再開されました | Cowen | Outperform |
2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
2021-03-15 | 開始されました | William Blair | Outperform |
2020-12-02 | 開始されました | Goldman | Neutral |
2020-09-09 | 開始されました | Morgan Stanley | Overweight |
2020-07-10 | 開始されました | Stifel | Buy |
2020-03-05 | 開始されました | Guggenheim | Buy |
2020-01-07 | 開始されました | Citigroup | Buy |
2019-10-07 | 開始されました | BofA/Merrill | Buy |
2019-10-07 | 開始されました | Cowen | Outperform |
2019-10-07 | 開始されました | JP Morgan | Overweight |
2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
Primecap Management Co. CA Grows Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Inc (TXG) Shares Up 4.21% on Nov 22 - GuruFocus.com
CIBC Asset Management Inc Sells 79,321 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Brown Capital Management LLC - MarketBeat
10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay Workflows - MSN
10 Best Genomics Stocks To Buy Right Now - Insider Monkey
10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance
LMR Partners LLP Invests $1.59 Million in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10X Genomics stock hits 52-week low at $13.98 amid market shifts - Investing.com India
10x Genomics (NASDAQ:TXG) Hits New 52-Week LowWhat's Next? - MarketBeat
Relative Strength Alert For 10x Genomics - Nasdaq
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Baillie Gifford & Co. - MarketBeat
10X Genomics' SWOT analysis: genomics firm's stock faces headwinds, eyes recovery - Investing.com
Sumitomo Mitsui Trust Group Inc. Grows Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Nikko Asset Management Americas, Inc. Expands Stake in 10x Genomics Inc. - GuruFocus.com
TXG10x Genomics, Inc. Latest Stock News & Market Updates - StockTitan
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference - BioSpace
ARK Investment Management LLC Purchases 1,436,582 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference – Company Announcement - Financial Times
10x Genomics Announces Preliminary Select Third Quarter 2024 Res - GuruFocus.com
10x Genomics Reports Third Quarter 2024 Financial Results - GuruFocus.com
10x Genomics Announces Mega-Scale Single Cell Analysis for One C - GuruFocus.com
Sumitomo Mitsui Trust Group's Strategic Acquisition in 10x Genomics Inc - GuruFocus.com
10x Genomics Inc (TXG) Trading 2.45% Higher on Nov 4 - GuruFocus.com
Barclays Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
Brokers Set Expectations for 10x Genomics FY2024 Earnings - MarketBeat
Allspring Global Investments Holdings LLC Has $880,000 Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - PR Newswire
10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript - Insider Monkey
10x Genomics Third Quarter 2024 Earnings: EPS Beats Expectations - Simply Wall St
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results - Benzinga
10x Genomics Inc (TXG) Trading 4.91% Higher on Oct 30 - GuruFocus.com
Citigroup Cuts 10x Genomics (NASDAQ:TXG) Price Target to $23.00 - MarketBeat
Canaccord keeps 10X Genomics shares at Buy list - Investing.com
10x Genomics (NASDAQ:TXG) Issues Earnings Results - MarketBeat
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
10x Genomics: Q3 Earnings Snapshot - The Advocate
10x Genomics shares sink 7% on revenue miss, lowered outlook - Investing.com
10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
10x Genomics falls 7% on 2024 revenue guidance cut - MSN
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
10x Genomics Inc Reports Q3 2024 Revenue of $151.7 Million, Missing Estimates; Gross Margin Improves to 70% - GuruFocus.com
10x Genomics shares sink 7% on revenue miss, lowered outlook By Investing.com - Investing.com UK
10x Genomics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com
10x Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
10x Genomics Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance
10X Genomics' SWOT analysis: stock faces headwinds amid strong consumables demand - Investing.com India
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):